Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis Celltrion gears up for subcutaneous infliximab launch in Europe Richard Staines biosimilars, Celltrion, IBD, infliximab, Rheumatoid arthritis 0 Comment Celltrion Healthcare’s subcutaneous (SC) formulation of its infliximab biosimilar, codenamed CT-P13 SC, looks set to launch in Europe Share X Celltrion gears up for subcutaneous infliximab launch in Europe https://pharmaphorum.com/views-analysis-market-access/celltrion-gears-up-for-subcutaneous-infliximab-launch-in-europe/
biosimilars, Celltrion, IBD, infliximab, Rheumatoid arthritis
0 Comment
